Capital One Financial Corp. vs Sanofi SA — how do they compare? Capital One Financial Corp. trades at $219.35 (market cap $134.45B), while Sanofi SA trades at $43.7 (market cap $104.30B). The key difference: Capital One Financial Corp. is the larger of the two by market cap, and Sanofi SA pays the higher dividend (5.55%). Which is the better fit depends on your goals.
| COF | SNY | |
|---|---|---|
Market Cap | $134.45B | $104.30B |
Sector | Financials | Health |
52-Week High | $257.94 | $52.34 |
52-Week Low | $176.10 | $41.33 |
Dividend Yield | 1.46% | 5.55% |
Enterprise Value | — | $124.19B |
Trailing returns across standard periods
Latest headlines on both assets
Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending.
Read more on COF →Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →